Format

Send to

Choose Destination
See comment in PubMed Commons below
Drugs. 2000 Mar;59(3):435-76.

Kinase inhibitors in cancer therapy: a look ahead.

Author information

1
Aventis Pharma Deutschland GmbH, Central Biotechnology, Marburg, Germany. Hans-Harald.Sedlacek@aventis.com

Abstract

The most essential kinases involved in cell membrane receptor activation, signal transduction and cell cycle control or programmed cell death and their interconnections are reviewed. In tumours, the genes of many of those kinases are mutated or amplified or the proteins are overexpressed. The use of key kinases offers the possibility to screen in vitro for synthetic small molecule kinase inhibitors. In view of the many interconnections of cellular kinases, their role in preventing or inducing programmed cell death and the possibility that a considerable number of signal transducing proteins are still unknown, cellular test systems are recommended in which the respective key kinase or one of its main partner molecules are overexpressed.

PMID:
10776829
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center